ABCA4 rs121908074: Vision Risks and Genetic Overview
The genetic variant rs121908074 represents a missense alteration, known clinically as p.Leu541Pro (c.1622T>C), located within the ABCA4 gene. In medical genomics, it is cataloged as a pathogenic variant contributing to inherited retinal conditions, predominantly autosomal recessive Stargardt disease and juvenile macular dystrophy. Because Stargardt disease typically follows a recessive inheritance pattern, individuals generally require a second disease-causing ABCA4 alteration in trans to exhibit clinical visual impairment.
What each genotype means
Typical ABCA4 genotype
This genotype represents the common, non-pathogenic sequence at this position in the ABCA4 gene. It is not associated with the specific p.Leu541Pro pathogenic change linked to Stargardt disease.
This is the most common genotype found in the general population.
ABCA4 variant carrier
This individual carries one copy of the p.Leu541Pro pathogenic variant. Because Stargardt disease is typically inherited in an autosomal recessive pattern, carrying a single copy is generally not sufficient to cause the condition, though it may be relevant for family planning or genetic counseling.
Carried by approximately 0.1% to 0.2% of individuals in European populations.
Increased risk of Stargardt
This genotype indicates the presence of two copies of the p.Leu541Pro pathogenic variant. This is associated with an increased risk of developing Stargardt disease or other ABCA4-related retinal dystrophies, which are characterized by juvenile-onset macular degeneration. Individuals with this result should consult with an ophthalmologist or a genetic counselor for clinical evaluation.
This genotype is extremely rare in the general population.
Genetic Architecture of rs121908074
The single nucleotide polymorphism rs121908074 is situated on chromosome 1 within the coding region of the ATP-binding cassette subfamily A member 4 (ABCA4) gene. At the nucleotide level, this alteration involves a substitution of thymine with cytosine (c.1622T>C). This point mutation leads to a non-conservative amino acid substitution of leucine with proline at position 541 (p.Leu541Pro) of the resulting polypeptide chain. Because proline introduces structural rigidity and alters polypeptide backbone angles, such substitutions can significantly destabilize the tertiary structure or folding of membrane-associated proteins. Clinical databases, such as NCBI ClinVar, track this variant due to its established association with monogenic forms of retinal degeneration, frequently noting its occurrence alongside complex alleles or in compound heterozygous states.
The Biological Role of the ABCA4 Transporter
The ABCA4 gene encodes a specialized ATP-binding cassette transporter localized primarily to the disc membranes of outer segments in rod and cone photoreceptor cells. Photoreceptors require ABCA4 to clear toxic visual cycle byproducts, specifically N-retinylidene-phosphatidylethanolamine (N-ret-PE), which forms after light activation of rhodopsin and cone opsins. Functioning as a lipid-flippase, ABCA4 transports these retinoid complexes across the disc membrane into the cytoplasm, facilitating the regeneration of 11-cis-retinal. When mutations like p.Leu541Pro impair this transport function, non-cleared retinoid conjugates accumulate within the photoreceptor discs. Over time, phagocytosis by retinal pigment epithelium (RPE) cells leads to toxic lipofuscin buildup, precipitating RPE atrophy, photoreceptor cell death, and gradual visual deterioration characteristic of macular dystrophies.
Clinical Evidence and Stargardt Disease Association
Extensive literature and database submissions catalog rs121908074 as a contributor to autosomal recessive Stargardt disease (STGD1) and related retinal dystrophies. Inherited retinal degenerations caused by ABCA4 follow a biallelic model where clinical expression requires loss of functional transporter capacity beyond a critical physiological threshold. In peer-reviewed cohorts and ClinVar curation, the p.Leu541Pro variant is frequently identified in compound heterozygosity—meaning the patient carries rs121908074 on one chromosome and a distinct pathogenic variant, such as a null mutation or a deep-intronic defect, on the homologous chromosome. Importantly, simple heterozygosity (carrying a single copy) is generally benign and does not typically produce juvenile-onset macular dystrophy in the absence of a complementary pathogenic variant.
Interpreting Results in Clinical and Personal Context
Identifying an altered allele at rs121908074 does not equate to an active diagnosis of retinal disease. Because Stargardt disease is a recessive trait, having one copy of the C allele designates an individual as an asymptomatic carrier in standard clinical genetics frameworks. A comprehensive diagnostic assessment requires phased genomic sequencing to confirm whether a second pathogenic mutation exists on the opposite chromosome, alongside clinical ophthalmic imaging such as optical coherence tomography (OCT) and fundus autofluorescence. Genetic testing findings should always be interpreted in collaboration with a board-certified genetic counselor or ophthalmologist. Consumers must avoid altering medical treatments, taking unverified supplements, or assuming clinical outcomes purely based on raw genotype files.
How common is this variant?
The rs121908074 variant is rare worldwide, with a minor allele frequency typically between 0.001 and 0.002 in populations of European ancestry, and it is observed at even lower frequencies or entirely absent in African and East Asian reference cohorts.
Frequently asked questions
What does a carrier status for rs121908074 mean for my vision?
Carrying a single copy of the rs121908074 variant (the CT genotype) typically does not cause vision loss on its own. Because conditions like Stargardt disease are autosomal recessive, a person generally needs two impaired ABCA4 copies—one from each biological parent—to manifest typical macular dystrophy symptoms.
Can diet or lifestyle prevent symptoms if I carry this variant?
While general eye health benefits from balanced nutrition, specific inherited forms of macular dystrophy cannot be prevented by lifestyle alone. Notably, clinical guidelines for Stargardt disease often caution patients against high-dose vitamin A supplementation, reinforcing the need to consult a specialist before taking vision-targeted dietary supplements.
How is rs121908074 inherited across generations?
This variant is inherited in a classic Mendelian fashion on an autosome (chromosome 1). A parent with one altered copy has a 50% probability of passing that variant to each child. A child would only be at risk of recessive disease if they also inherit a complementary pathogenic mutation from the other parent.
Why does ABCA4 show different symptoms in different people?
The severity of ABCA4-related retinopathy depends heavily on the total remaining functional protein produced by both gene copies. Combinations of mild, severe, and deep-intronic variants create a broad spectrum of visual outcomes ranging from early-onset juvenile Stargardt disease to late-onset macular changes.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908074?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCA4
A variant in the ABCA4 gene associated with Stargardt disease.
Pathogenic missense variant in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Genomic variant within the ATP-binding cassette retinal transporter ABCA4 locus implicated in retinal degenerations and macular disease.
Known as the Gly1961Glu (G1961E) variant in ABCA4, a prevalent hypomorphic mutation contributing to late-onset Stargardt disease and cone-rod dystrophy.
A well-documented pathogenic missense change in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.
Pathogenic missense variant (p.Gly1961Glu) in ABCA4 causing Stargardt disease and macular degeneration phenotypes.